Background: Transcranial magnetic stimulation (TMS) is a new technology for
noninvasively stimulating the brain, Several studies have suggested that d
aily stimulation of the left prefrontal cortex with TMS for 2 weeks has pro
bable antidepressant effects. We conducted a parallel-design, double-masked
, sham-controlled study to address whether 2 weeks of daily TMS over the le
ft prefrontal cortex has antidepressant activity greater than sham.
Methods: Thirty medication-free adult outpatients with nonpsychotic, major
depressive (n = 21) or bipolar (n = 9) (depressed phase) disorder who were
in a current major depression (Hamilton Rating Scale for Depression [HRSD]
21-item score of >18) were treated each weekday for 2 weeks. Subjects were
randomly assigned to receive either daily active (20 subjects) or sham (10
subjects) stimulation. Additionally, the 20 active subjects I were equally
divided between slower (5 Hz) andfaster (20 Hz) frequency treatment. Antide
pressant response was defined as greater than a 50% improvement in the base
line HRSD,
Results: Active TMS resulted in significantly more responders (9/20) than d
id sham (0/10) (chi (2) = 6.42, p < .01), The number of responders did not
differ significantly between the two active cells (3/10 faster and 6/10 slo
wer). Expressed as a percent change from baseline, active TMS subjects had
significantly greater improvement on the Beck Depression Inventory as well
as the Hamilton Anxiety Rating Scale than did those who received sham.
Conclusions: Daily left prefrontal TMS for 2 weeks significantly reduced de
pression symptoms greater than did sham, The two forms of active TMS treatm
ent did not differ significantly, (C) 2000 Society of Biological Psychiatry
.